Additional ICD10
  • AK - Alaska
  • AL - Alabama
  • AR - Arkansas
  • AS - American Samoa
  • AZ - Arizona
  • CA - California - Entire State
  • CO - Colorado
  • CT - Connecticut
  • DC - District of Columbia
  • DE - Delaware
  • FL - Florida
  • GA - Georgia
  • GU - Guam
  • HI - Hawaii
  • IA - Iowa
  • ID - Idaho
  • IL - Illinois
  • IN - Indiana
  • KS - Kansas
  • KY - Kentucky
  • LA - Louisiana
  • MA - Massachusetts
  • MD - Maryland
  • ME - Maine
  • MI - Michigan
  • MN - Minnesota
  • MO - Missouri - Entire State
  • MS - Mississippi
  • MT - Montana
  • NC - North Carolina
  • ND - North Dakota
  • NE - Nebraska
  • NH - New Hampshire
  • NJ - New Jersey
  • NM - New Mexico
  • NV - Nevada
  • NY - New York - Entire State
  • OH - Ohio
  • OK - Oklahoma
  • OR - Oregon
  • PA - Pennsylvania
  • PR - Puerto Rico
  • RI - Rhode Island
  • SC - South Carolina
  • SD - South Dakota
  • TN - Tennessee
  • TX - Texas
  • UT - Utah
  • VA - Virginia
  • VI - Virgin Islands
  • VT - Vermont
  • WA - Washington
  • WI - Wisconsin
  • WV - West Virginia
  • WY - Wyoming
  • CNMI - Northern Mariana Islands
  • EM - Missouri - Northeastern & Southern
  • WM - Missouri - Northwestern
  • DN - New York - Downstate
  • QN - New York - Queens
  • UN - New York - Upstate
  • NF - California - Northern
  • SF - California - Southern
Showing results for all states.
Filter:
ICD10 CODE AND DESCRIPTIONLCD CODENCD CODE
C22.0 - Liver cell carcinoma——
C22.1 - Intrahepatic bile duct carcinoma——
C22.2 - Hepatoblastoma——
C22.3 - Angiosarcoma of liver——
C22.4 - Other sarcomas of liver——
C22.7 - Other specified carcinomas of liver——
C22.8 - Malignant neoplasm of liver, primary, unspecified as to type——
C22.9 - Malignant neoplasm of liver, not specified as primary or secondary——
C80.0 - Disseminated malignant neoplasm, unspecified——
C80.1 - Malignant (primary) neoplasm, unspecified——
C80.2 - Malignant neoplasm associated with transplanted organ——
D59.0 - Drug-induced autoimmune hemolytic anemia——
D59.1 - Other autoimmune hemolytic anemias——
D59.10 - Autoimmune hemolytic anemia, unspecified——
D59.11 - Warm autoimmune hemolytic anemia——
D59.12 - Cold autoimmune hemolytic anemia——
D59.13 - Mixed type autoimmune hemolytic anemia——
D59.19 - Other autoimmune hemolytic anemia——
D59.2 - Drug-induced nonautoimmune hemolytic anemia——
D59.3 - Hemolytic-uremic syndrome——
D59.30 - Hemolytic-uremic syndrome, unspecified——
D59.31 - Infection-associated hemolytic-uremic syndrome——
D59.32 - Hereditary hemolytic-uremic syndrome——
D59.39 - Other hemolytic-uremic syndrome——
D59.4 - Other nonautoimmune hemolytic anemias——
D59.5 - Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]——
D59.6 - Hemoglobinuria due to hemolysis from other external causes——
D59.8 - Other acquired hemolytic anemias——
D59.9 - Acquired hemolytic anemia, unspecified——
D64.0 - Hereditary sideroblastic anemia——
D64.1 - Secondary sideroblastic anemia due to disease——
D64.2 - Secondary sideroblastic anemia due to drugs and toxins——
D64.3 - Other sideroblastic anemias——
D64.4 - Congenital dyserythropoietic anemia——
D64.8 - Other specified anemias——
D64.81 - Anemia due to antineoplastic chemotherapy——
D64.89 - Other specified anemias——
D64.9 - Anemia, unspecified——
D68.0 - Von Willebrand disease——
D68.00 - Von Willebrand disease, unspecified——
D68.01 - Von Willebrand disease, type 1——
D68.02 - Von Willebrand disease, type 2——
D68.020 - Von Willebrand disease, type 2A——
D68.021 - Von Willebrand disease, type 2B——
D68.022 - Von Willebrand disease, type 2M——
D68.023 - Von Willebrand disease, type 2N——
D68.029 - Von Willebrand disease, type 2, unspecified——
D68.03 - Von Willebrand disease, type 3——
D68.04 - Acquired von Willebrand disease——
D68.09 - Other von Willebrand disease——